ABL1 and chronic myelogenous leukemia, BCR-ABL1 positive: As shown in Figure 6C, the cell differentiation of BaF3-T315I induced by I13 was attributed to the inhibition of the chronic myeloid leukemia signaling pathway, which was involved in BCR-ABL regulation (https://www.kegg.jp/pathway/map05220).